Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy
- Resource Type
- Review Article
- Source
- In
Journal of Neuroimmunology 15 December 2014 277(1-2):6-12 - Subject
- Language
- ISSN
- 0165-5728